IPO Date: 6 May - 8 May 2024
Listing Date: 13 May 2024
Price Range
₹430 to ₹452 per share
Issue Size
1841.76 Cr
Min Investment
₹14,190
Lot Size
33 Shares
Issue open date
6 May 2024
Issue close date
8 May 2024
UPI mandate deadline
8 May 2024 (5 PM)
Allotment finalization
9 May 2024
Share credit
10 May 2024
Listing date
13 May 2024
Mandate end date
N/A
| Funds Raised in the IPO | Amount |
|---|---|
| Overall | 1841.76 Cr |
| Fresh Issue | 0 Cr |
| Offer for Sale | 0 Cr |
| Allotment Timeline | Details |
|---|---|
| Allotment Date | 9 May 2024 |
| Allotment Link | {Link} |
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
| Date | Ipo Price | GMP | Estimated Listing Price |
|---|
| Issue Price | Listing Gain | Current Market Price | P/L |
|---|---|---|---|
| ₹430 to ₹452 per share | ₹ 3028 (26.31%) | ₹ 534 | 18.14% |
Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.
| Founded in | 1998 |
| Managing director | |
| Parent organization |
| Category | Subscription (No. of times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | 192.72 |
| Non-Institutional Investors (NIIs) | 55.91 |
| Retail Individual Investors (RIIs) | 7.86 |
| Employee | 6.62 |
| Total | 70.3 |